|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US9549999||GE HEALTHCARE||Radiopharmaceutical composition|| |
(6 years from now)
Myoview is owned by Ge Healthcare.
Myoview contains Technetium Tc-99M Tetrofosmin Kit.
Myoview has a total of 1 drug patent out of which 0 drug patents have expired.
Myoview was authorised for market use on 09 February, 1996.
Myoview is available in injectable;injection dosage forms.
The generics of Myoview are possible to be released after 10 March, 2030.
Market Authorisation Date: 09 February, 1996
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic